At a glance
- Originator Nonindustrial source
- Class Antiulcers
- Mechanism of Action Cholecystokinin B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Gastric ulcer; Pancreatitis
Most Recent Events
- 03 Nov 1998 No-Development-Reported for Gastric ulcer in United Kingdom (Unknown route)
- 03 Nov 1998 No-Development-Reported for Pancreatitis in United Kingdom (Unknown route)
- 02 Dec 1996 Preclinical development for Gastric ulcer in United Kingdom (Unknown route)